Amdipharm Mercury, Concordia Healthcare deal

Concordia will acquire fellow generic and pharmaceutical company Amdipharm from private equity firm Cinven for up to $3.6

Read the full 180 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE